Medicare Enrolled
Lilia Aguila, APRN
Nurse Practitioner - Family · Ocala, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Aguila from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Aguila?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Aguila
Lilia Aguila is a nurse practitioner - family in Ocala, FL, with 6 years of NPI registration. Based on federal Medicare data, Aguila performed 604 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Aguila received a total of $9,531 from 69 pharmaceutical and/or device companies across 402 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Aguila is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 6 years of NPI registration
▲ Top 27% volume in FL
$9,531 industry payments
Florida License Status
FL DOH · MQA2
Active licenses
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Registered Nurse | 9375653 | Clear | April 30, 2027 | — |
| Advanced Practice Registered Nurse | 11004002 | Clear | April 30, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗604
Medicare services
Top 27% in FL for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
231 | $81 | $224 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $59 | $148 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $106 | $343 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $117 | $301 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $9 | $93 |
| New patient office visit, complex (60-74 min) | 34 | $139 | $432 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
20 | $10 | $105 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
17 | $84 | $686 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
16 | $21 | $249 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
16 | $1 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.1% high complexity
9.3% medium
82.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,531
Total received (2021-2024)
Avg $2,383/year across 4 years
Top 2% in FL for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
402
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,517
2023
$3,220
2022
$2,672
2021
$123
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$325
PFIZER INC.
$259
Daiichi Sankyo Inc.
$171
E.R. Squibb & Sons, L.L.C.
$170
Genmab U.S., Inc.
$162
Eisai Inc.
$157
JAZZ PHARMACEUTICALS INC.
$136
AstraZeneca Pharmaceuticals LP
$133
Merck Sharp & Dohme LLC
$123
Gilead Sciences, Inc.
$120
Astellas Pharma US Inc
$117
Alexion Pharmaceuticals, Inc.
$116
Takeda Pharmaceuticals U.S.A., Inc.
$116
Lilly USA, LLC
$109
Incyte Corporation
$101
SEAGEN INC.
$95
Novocure Inc.
$89
Celgene Corporation
$82
Janssen Biotech, Inc.
$78
PharmaEssentia USA Corporation
$75
Bayer Healthcare Pharmaceuticals Inc.
$72
Ipsen Biopharmaceuticals, Inc
$71
Pharmacosmos Therapeutics Inc.
$69
Regeneron Healthcare Solutions, Inc.
$69
Genentech USA, Inc.
$65
Rigel Pharmaceuticals, Inc.
$47
EMD Serono, Inc.
$45
Apellis Pharmaceuticals, Inc.
$43
GlaxoSmithKline, LLC.
$35
Stemline Therapeutics Inc.
$30
SOBI, INC
$30
Mirati Therapeutics, Inc.
$25
GENZYME CORPORATION
$24
Azurity Pharmaceuticals, Inc.
$23
Agios Pharmaceuticals, Inc.
$19
Geron Corporation
$19
ARRAY BIOPHARMA INC
$18
Aveo Pharmaceuticals, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
Myriad Genetic Laboratories, Inc.
$16
ABBVIE INC.
$14
Coherus Biosciences Inc.
$14
Top 3 companies account for 21.5% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$703
Novartis Pharmaceuticals Corporation
$642
PFIZER INC.
$534
Lilly USA, LLC
$493
Merck Sharp & Dohme LLC
$467
E.R. Squibb & Sons, L.L.C.
$438
Seagen Inc.
$349
Daiichi Sankyo Inc.
$323
Incyte Corporation
$320
Takeda Pharmaceuticals U.S.A., Inc.
$298
PharmaEssentia USA Corporation
$284
Genmab U.S., Inc.
$283
JAZZ PHARMACEUTICALS INC.
$267
Gilead Sciences, Inc.
$254
Astellas Pharma US Inc
$237
Janssen Biotech, Inc.
$234
Eisai Inc.
$223
Regeneron Healthcare Solutions, Inc.
$181
Bayer Healthcare Pharmaceuticals Inc.
$173
Amgen Inc.
$169
GENZYME CORPORATION
$140
Genentech USA, Inc.
$139
Stemline Therapeutics Inc.
$122
Myriad Genetic Laboratories, Inc.
$119
Alexion Pharmaceuticals, Inc.
$116
Celgene Corporation
$113
GlaxoSmithKline, LLC.
$104
Octapharma USA, Inc.
$96
SEAGEN INC.
$95
Pharmacosmos Therapeutics Inc.
$94
Pharmacyclics LLC, An AbbVie Company
$90
Novocure Inc.
$89
EISAI INC.
$85
Janssen Scientific Affairs, LLC
$78
EMD Serono, Inc.
$77
Mirati Therapeutics, Inc.
$76
Pharmacyclics LLC, an AbbVie Company
$76
G1 Therapeutics, Inc.
$75
Rigel Pharmaceuticals, Inc.
$73
Ipsen Biopharmaceuticals, Inc
$71
SOBI, INC
$66
AVEO Pharmaceuticals, Inc.
$65
Apellis Pharmaceuticals, Inc.
$60
SERVIER PHARMACEUTICALS LLC
$45
Agios Pharmaceuticals, Inc.
$38
Immunocore Limited
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
TerSera Therapeutics LLC
$24
Deciphera Pharmaceuticals Inc.
$24
Azurity Pharmaceuticals, Inc.
$23
Kyowa Kirin, Inc.
$22
AbbVie Inc.
$20
ADC Therapeutics America, Inc.
$19
Geron Corporation
$19
Karyopharm Therapeutics Inc.
$18
MorphoSys, US Inc.
$18
ARRAY BIOPHARMA INC
$18
Puma Biotechnology, Inc.
$18
GE HealthCare
$18
Ironshore Pharmaceuticals Inc.
$18
Aveo Pharmaceuticals, Inc.
$18
Sobi, Inc
$18
Heron Therapeutics, Inc.
$16
Verity Pharmaceuticals Inc.
$15
TAIHO ONCOLOGY, INC.
$15
ABBVIE INC.
$14
Dova Pharmaceuticals
$14
Coherus Biosciences Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 19.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · Aliqopa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Blincyto · CALQUENCE · CERDELGA · CINVANTI · COSELA · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · JORNAY PM · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · RYTELO · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · Vanflyta · Venclexta · XPOVIO · XTANDI · Xospata · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
402
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Aguila is a clinical cardiology specialist, with above-average Medicare volume (top 27% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Aguila experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Aguila performed 231 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Aguila receive payments from pharmaceutical companies?
Yes. Aguila received a total of $9,531 from 69 companies across 402 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Aguila's costs compare to other family nurse practitioners in Ocala?
Aguila's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Aguila) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Ocala
Browse family nurse practitioners in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in FL
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in FL
Which FL family nurse practitioners receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology